Home Cart Sign in  
Chemical Structure| 883065-90-5 Chemical Structure| 883065-90-5
Chemical Structure| 883065-90-5

BI-78D3

CAS No.: 883065-90-5

BI-78D3 is a selective and competitiveJNK inhibitor with IC50 of 280 nM.

Synonyms: JNK Inhibitor X; c-Jun N-terminal Kinase Inhibitor X

4.5 *For Research Use Only !

Cat. No.: A166355 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÇǶÊÊ Inquiry Inquiry
5mg ł§§¶ÊÊ Inquiry Inquiry
10mg łÿ˶ÊÊ Inquiry Inquiry
25mg łóó¶ÊÊ Inquiry Inquiry
50mg łÇÍʶÊÊ Inquiry Inquiry
100mg łÇóͶÊÊ Inquiry Inquiry
250mg łËî§¶ÊÊ Inquiry Inquiry
1g łďòǶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÇǶÊÊ

  • 5mg

    ł§§¶ÊÊ

  • 10mg

    łÿ˶ÊÊ

  • 25mg

    łóó¶ÊÊ

  • 50mg

    łÇÍʶÊÊ

  • 100mg

    łÇóͶÊÊ

  • 250mg

    łËî§¶ÊÊ

  • 1g

    łďòǶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of BI-78D3

CAS No. :883065-90-5
Formula : C13H9N5O5S2
M.W : 379.37
SMILES Code : [O-][N+](=O)C1=CN=C(SC2=NNC(=O)N2C2=CC3=C(OCCO3)C=C2)S1
Synonyms :
JNK Inhibitor X; c-Jun N-terminal Kinase Inhibitor X
MDL No. :MFCD01313575
InChI Key :QFRLDZGQEZCCJZ-UHFFFAOYSA-N
Pubchem ID :2747117

Safety of BI-78D3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of BI-78D3

MAPK
TLR

Isoform Comparison

Biological Activity

Target
  • JNK1

    JNK, IC50:280 nM

  • JNK

    JNK, IC50:280 nM

  • JNK2

    JNK, IC50:280 nM

  • JNK3

    JNK, IC50:280 nM

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.64mL

0.53mL

0.26mL

13.18mL

2.64mL

1.32mL

26.36mL

5.27mL

2.64mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories